Mouthguard made at least partially from an edible candy
A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120014934 | Enhanced Natural Colors A natural color is concentrated to intensify color range and to provide useful amounts of one or more of anti-oxidant, nutritional, and anti-inflammatory compounds derived from one or more pigment sources. In a preferred embodiment, the pigment source is a fruit, a vege... | 01/19/2012 |
| 20110318321 | CONTROLLED RELEASE PHARMACEUTICAL OR FOOD FORMULATION AND PROCESS FOR ITS PREPARATION The present invention relates to a controlled release pharmaceutical or food formulation comprising at least one active pharmaceutical or food ingredient dispersed in a mixture of a glycogen with a polysaccharide, and the process for its preparation. The invention also ... | 12/29/2011 |
| 20110305781 | Use of Eclipta Prostrata and Other PPAR-GAMMA Inhibitors in Cosmetics and Compositions Thereof The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite,... | 12/15/2011 |
| 20110280962 | METALLIZATION DEVICE AND METHOD The present invention concerns a topical formulation for the treatment of cellulite, comprising alfalfa herb and derivatives thereof and can further comprise melatonine. The invention refers also to a method of application of said formulati... | 11/17/2011 |
| 20110256118 | ANTIOXIDANT-CONTAINING FOOD COMPOSITION FOR USE IN ENHANCING ANTIVIRAL IMMUNITY IN COMPANION ANIMALS The invention encompasses methods for enhancing the ability of a companion animal to resist and/or overcome viral infections. The methods of the invention include an amount of lipoic acid that is effective in enhancing the antiviral immunity of a companion animal.... | 10/20/2011 |
| 20110250300 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS The present invention features methods for treating or preventing conditions, diseases, or disorders related to oxidative stress. In one embodiment, the method increases Nrf2 biological activity or expression. In particular, the invention provides for the treatment or p... | 10/13/2011 |
| 20110236508 | L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the adsorption of l-arginine to the blood system and to introduce high levels... | 09/29/2011 |
| 20110230816 | Gels for Transdermal Delivery The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as co... | 09/22/2011 |
| 20110217252 | COMPOUND USEFUL FOR TREATING CELLULITE It is described the use of propionyl L-carnitine for treating disturbances of the skin such as cellulite.... | 09/08/2011 |
| 20110189161 | NUTRIGENOMICS METHODS AND COMPOSITIONS The present invention provides a proprietary compositions and systems to modulate genetic and metabolomic contributing factors affecting disease diagnosis, stratification, and prognosis, as well as the metabolism, efficacy and/or toxicity associated with specific vitami... | 08/04/2011 |
| 20110189318 | METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS The present invention provides methods for enhancing expression of a redox-associated factor, wherein kaempferol, quercetin or glycosides thereof, or any combination thereof is used as an active ingredient, and methods for enhancing expression of a redox-associated fact... | 08/04/2011 |
| 20110182885 | FORMULATIONS AND TREATMENTS FOR WELL-BEING A formulation for well-being in humans including: extracts from the herbal varieties, Polygonum multiflorum, Panax quinquefolium, Gingko biloba, and Equisetum arvense; beta sitosterol methyl sulfonyl methane; soy isoflavones; levo-arginine; inositol; niaci... | 07/28/2011 |
| 20110171328 | PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES The invention discloses a pharmaceutical composition for synergistically treating and preventing diabetic complication. The composition contains 1-deoxynojirimycin and fagomine, and the weight ration of the 1-deoxynojirimycin to the fagomine is 0.5-5:1.... | 07/14/2011 |
| 20110159123 | Composition For Relieving Premenstrual Syndrome A composition is provided for relieving premenstrual syndrome. The composition comprises about 5% to about 95% by weight of a tribulus terrestris extract and about 5% to about 95% by weight of one or more herbal extracts selected from organic white willow extract, Red r... | 06/30/2011 |
| 20110142956 | USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS The invention relates to the use of PDE5 inhibitors for treating and/or preventing hypopigmentary disorders.... | 06/16/2011 |
| 20110117194 | PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a pharmaceutical formulation comprising an immediate-release compartment and an extended... | 05/19/2011 |
| 20110091585 | HERBAL COMPOSITIONS AND METHODS FOR ENHANCING VITAL ENERGY AND ATHLETIC PERFORMANCE Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herb... | 04/21/2011 |
| 20110085992 | COMPOSITION FOR PREVENTING INFECTION OF NEW INFLUENZA A (H1N1) VIRUS COMPRISING GINKGO EXTRACT, AIR FILTER COMPRISING THE SAME, AND AIR CLEANING DEVICE COMPRISING THE FILTER Disclosed are a composition for the prophylaxis of new influenza A (H1N1) virus infection comprising a ginkgo extract, an air filter coated with the same, and an air cleaner comprising the air filter. Having high inhibitory activity against new influenza A (H1N1)... | 04/14/2011 |
| 20110086119 | Preparation for the relief of disease A composition including (a) a Platelet Activating Factor (PAF) Inhibitor and (b) an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity. The composition is useful for the treatment or the relief of inflammatory diseases, thro... | 04/14/2011 |
| 20110086118 | COMPOSITION FOR PREVENTION OF INFLUENZA VIRAL INFECTION COMPRISING SUMAC EXTRACT, AIR FILTER COMPRISING THE SAME AND AIR CLEANING DEVICE COMPRISING THE FILTER Disclosed are a composition for the prophylaxis of influenza viral infection comprising a sumac extract, an air filter coated with the same, and an air cleaner comprising the air filter. Having high inhibitory activity against influenza virus, the composition comprising... | 04/14/2011 |
| 20110070316 | Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for applic... | 03/24/2011 |
| 20110038813 | Novel Compositions Against Alkyl-Acyl GPC, The Derivatives And Products Thereof The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteo-hormones and at least one mineral, one constituent by preference from the group consis... | 02/17/2011 |
| 20110033556 | Natural Pharmaceutical Preparations for Increasing Albumin A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating He... | 02/10/2011 |
| 20100310653 | USE OF AN EXTRACT MADE OF LEAVES OF GINKGO BILOBA The present invention relates to the use of an extract made of leaves of Ginkgo biloba for the production of a preparation, or an extract made of leaves of Ginkgo biloba as an agent for the treatment and prophylaxis of the dementia syndrome, the early stag... | 12/09/2010 |
| 20100303784 | PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
| 12/02/2010 |
| 20100285147 | CRUDE DRUG EXTRACT-BLENDED LIQUID MEDICINE Provided an acidic liquid preparation containing a herb and/or animal-origin extract at high concentration to suppress time-dependent occurrence of precipitation and/or opacity. A liquid preparation containing a herb-origin extract having p... | 11/11/2010 |
| 20100247688 | PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS The present invention relates to a compound that is capable of inhibiting the formation of β-amyloid plaques, of reducing and/or retarding the increase the β-amyloid plaque load in the brain of an animal, particularly a mammal, but especially a human. In particular, t... | 09/30/2010 |
| 20100233304 | COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS Compositions comprising one or more unsaturated fatty acids and one or more nitric oxide releasing compounds, and methods for using such compositions for enhancing cognitive function, reducing or preventing a decline of social interaction, reducing or preventing age-rel... | 09/16/2010 |
| 20100233301 | TOPICAL COMPOSITIONS COMPRISING FERMENTED EXTRACTS OF TRADITIONAL CHINESE MEDICINAL (TCM) INGREDIENTS, AND METHODS OF MAKING AND USING SAME The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for differe... | 09/16/2010 |
| 20100215774 | FILM COMPRISING NITROGLYCERIN The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin and/or other active drugs through the mucosal tissues of the oral cavity. The films inclu... | 08/26/2010 |
| 20100203103 | THERAPEUTIC COMPOSITIONS FOR TREATMENT OF INFLAMMATION OF OCULAR AND ADNEXAL TISSUES The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also di... | 08/12/2010 |
| 20100196496 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of vario... | 08/05/2010 |
| 20100189818 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a ne... | 07/29/2010 |
| 20100151064 | THIAZOLHYDRAZIDES FOR TREATMENT OF NEURODEGENERATIVE DISEASES Described are compounds having a thiazolhydrazide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said... | 06/17/2010 |
| 20100112104 | COSMETIC PREPARATIONS DESIGNED TO REDUCE UNSIGHTLY CELLULITE The invention relates to a new derivative of aryldimethylpyrazolone of formula (I) which is effective in reducing unsightly cellulite, and compositions containing it. ... | 05/06/2010 |
| 20100080764 | Skin Treatment Systems A basic facial and body treatment cosmetic formulation is a combination of a cationic emulsifying agent, an oil soluble liquid polymer and a naturally occurring lactate buffer system. The basic formulation is a starter system that can be specialized to skin moisturizers... | 04/01/2010 |
| 20100068259 | NATURAL PRODUCT INHIBITORS OF 3DG Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that i... | 03/18/2010 |
| 20100062067 | COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT A composition comprising lipid and surfactant, characterised in that the lipid and surfactant are in the form of macromolecular assemblies of less than 100 nm in diameter. The surfactant can have a HLB number of less than 20, or be an ether or ester surfactant, or be io... | 03/11/2010 |
| 20100028318 | AGENT FOR RELIEF OR PREVENTION OF XEROSTOMIA The present invention has its object to provide a safer and highly effective composition capable of relieving or preventing xerostomia. The present invention relates to an agent for relieving or preventing xerostomia comprising an oxidized coenzyme Q and/or a reduced co... | 02/04/2010 |
| 20100015259 | Composition and method for improving human concentration, memory and other cognitive brain This formulaic composition has synergistic effects on the mental function of humans including reduction of mental fatigue, maintenance and enhancement of concentration and mental vigor. The main components are theanine, at levels in excess of 200 mg/dose, and Gingko Bil... | 01/21/2010 |